Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 2/20 | 1.00 |
| ▸ | RAD1 | O60671 | 1/20 | 1.00 |
| ▸ | RAD51 | Q06609 | 6/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | LTA | P01374 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.53 |
| ▸ | SENP1 | Q9P0U3 | 5/20 | 0.53 |
| ▸ | SENP3 | Q9H4L4 | 4/20 | 0.53 |
| ▸ | SUMO2 | P61956 | 3/20 | 0.53 |
| ▸ | SUMO1 | P63165 | 3/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.53 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350628 | 1.00 | P2RY6 (1.00) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL38212 | 1.00 | P2RY6 (1.00) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL29351286 | 1.00 | P2RY6 (1.00) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL27168234 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL2286120 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL439381 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL31481692 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL15823889 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL439383 | 0.98 | P2RY6 (0.97) | P2RY6RAD1RAD51KDM4EUSP2 | |
| SCHEMBL11231850 | 0.93 | RAD1 (0.86) | P2RY6RAD1RAD51KDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4318 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059144-A1 | DYNAMIC NANOMECHANICAL AMPLIFICATION ANTENNA AND USES | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2025-03-20 | — | — | WO | claimed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | claimed |
| US-11725222-B2 | Cleavable nucleotide analogs and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-15 | — | — | US | claimed |
| WO-2023069727-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPROLIFERATIVE, INFLAMMATORY, AND IMMUNOLOGICAL DISEASES, AND INFECTIONS | EDISON ONCOLOGY (US) | 2023-04-27 | — | — | WO | claimed |
| EP-4121564-A1 | BIOMARKERS FOR SACITUZUMAB GOVITECAN THERAPY | Immunomedics, Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| US-20220237930-A1 | CELL AGE CLASSIFICATION AND DRUG SCREENING | FOUNTAIN THERAPEUTICS INC (US) | 2022-07-28 | — | — | US | claimed |
| EP-3244899-B1 | PROSTAGLANDIN TRANSPORTER INHIBITORS FOR INHIBITING OVULATION | TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD (IL) | 2021-11-24 | — | — | EP | claimed |
| US-20210338579-A1 | pH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS AND MICELLES THAT INHIBIT MCT 1 AND RELATED PROTEINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-11-04 | — | — | US | claimed |
| WO-2021188896-A1 | BIOMARKERS FOR SACITUZUMAB GOVITECAN THERAPY | IMMUNOMEDICS, INC. (US) | 2021-09-23 | — | — | WO | claimed |
| US-20210275693-A1 | MODIFIED WOUND DRESSINGS | CONVATEC TECHNOLOGIES INC. | 2021-09-09 | — | — | US | claimed |
| US-5705530-A | SIDE EFFECT REDUCTION; GLAUCOMA TREATMENT | ALLERGAN (US) | 1998-01-06 | — | — | US | claimed |
| EP-0786994-A2 | USE OF CHLORIDE CHANNEL BLOCKERS FOR REDUCING INTRAOCULAR PRESSURE | Allergan (US) | 1997-08-06 | — | — | EP | claimed |
| US-5565322-A | PHOTOELECTRIC DEVICES; DETECTORS; MEDICAL DIAGNOSIS | NANOGEN, INC. (US) | 1996-10-15 | — | — | US | claimed |
| US-5559151-A | Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers | ALLERGAN (US) | 1996-09-24 | — | — | US | claimed |
| US-5532129-A | Self-organizing molecular photonic structures based on chromophore- and fluorophore-containing polynucleotides and methods of their use | ENTERPRISE PARTNERS II, L.P. (US) | 1996-07-02 | — | — | US | claimed |
| WO-1996016647-A2 | USE OF CHLORIDE CHANNEL BLOCKERS FOR REDUCING INTRAOCULAR PRESSURE | ALLERGAN (US) | 1996-06-06 | — | — | WO | claimed |
| US-5494932-A | AIDS, RETROVIRUSES, HERPES VIRUSES, CYTOMEGALOVIRUS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1996-02-27 | — | — | US | claimed |
| EP-0498095-B1 | Sulfonic stilbene derivatives in the treatment of viral diseases | MERRELL DOW PHARMA (US) | 1995-01-04 | — | — | EP | claimed |
| US-5280015-A | 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-01-18 | — | — | US | claimed |
| EP-0498095-A1 | Sulfonic stilbene derivatives in the treatment of viral diseases | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-08-12 | — | — | EP | claimed |